Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Intec Pharma (NASDAQ:NTEC) With a Buy

ME Staff
-
0

Analyst Ratings For Intec Pharma (NASDAQ:NTEC)

Today, Ladenburg Thalmann Financial Services initiated coverage on Intec Pharma (NASDAQ:NTEC) with a Buy.

Some recent analyst ratings include

  • 2/28/2018-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
  • 2/26/2018-HC Wainwright initiated coverage with a Buy rating.
  • 9/21/2017-CIBC Reiterated Rating of Outperform .


    Recent Trading Activity for Intec Pharma (NASDAQ:NTEC)
    Shares of Intec Pharma closed the previous trading session at 6.00 up +0.10 1.69% with shares trading hands.